跳至主要内容
临床试验/JPRN-UMIN000003634
JPRN-UMIN000003634已完成1 期

Phase I Study of definitive chemoradiotherapy with Docetaxel, CDDP and 5-FU for Unresectable or Recurrent Esophageal Cancer - Phase I Study of definitive chemoradiotherapy with Docetaxel, CDDP and 5-FU for Unresectable or Recurrent Esophageal Cancer

Department of Surgery, Graduate School of Medicine, Osaka University0 个研究点目标入组 18 人开始时间: 2010年5月18日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients have serious complications (heart disease, pulmonary fibrosis, interstitial pneumonia, hemorrhagic tendency and so on) 2. active infection 3. active synchronous malignancy 4. esophagotracheal or esophagobronchial fistulas 5. peripheral neuropathy or edema >= Grade 2 (CTCAE version3) 6. history of serious drug hypersensitivity 7. brain metastasis 8. pregnant or lactation women, or women with the possibility of the pregnancy and men who want let to pregnancy 9. patients who are judged inappropriate for the entry into study by the investigator

研究者

发起方
Department of Surgery, Graduate School of Medicine, Osaka University

相似试验

Phase I Study of definitive chemoradiotherapy with... | 临床试验